|
ViramuneDrug - Viramune The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Nevirapine
Strength -
50MG/5ML
Applicant -
BOEHRINGER INGELHEIM
New Drug Application (NDA) Number -
020933
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 11, 1998
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Boehringer Ingelheim Pharmaceuticals Inc
Viramune
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical Nevanac 0.1% Suspension/drops; Ophthalmic Natrecor 1.5mg/vial For Solution; Intravenous Netromycin Eq 100mg Base/ml Injectable; Injection Netromycin Eq 10mg Base/ml Injectable; Injection Netromycin Eq 25mg Base/ml Injectable; Injection Viramune 50mg/5ml Suspension; Oral Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Mytrex A Eq 3.5mg Base/gm;0.1% Ointment; Topical NewDrugInformation |